Skip to main content

Advertisement

Log in

Plasma Melatonin and Urinary 6-Hydroxymelatonin Levels in Patients with Pulmonary Tuberculosis

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Tuberculosis (TB) is the second most frequent cause of death in the world, after AIDS. Delay in diagnosing TB is an important worldwide problem. It seriously threatens public health. Cell-mediated immune responses play an important role in the pathogenesis of TB infection. The course of Mycobacterium tuberculosis (MTb) infection is regulated by two distinct T cell cytokine patterns. Melatonin is a biomolecule (mainly secreted by the pineal gland) with free radical scavenging, antioxidant and immunoregulatory properties. Melatonin has both its direct and indirect immunomodulatory effects on the immune system. In this study, we measured plasma melatonin and urine 6-hydroxy melatonin sulphate (6-HMS) concentrations in patients with newly diagnosed TB for the purpose of investigating whether there was a relationship between their levels and MTb infection. Thirty-one newly diagnosed patients presenting with active TB and 31 healthy subjects as the control group were included in this study. Blood and 24-h urine samples were collected from all individuals. Plasma melatonin levels and urine 6-HMS were measured. Our results show that in patients with TB, mean melatonin and 6-HMS concentrations were significantly lower than in the control subjects (p = 0.037, p < 0.001, respectively). We believe that the treatment of TB patients with melatonin might result in a wide range of health benefits including improved quality of life and reduced severity of infection in these patients. Supplementation with melatonin may be considered as an adjunctive therapy to classic treatment of pulmonary TB, especially during the acute phase of infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Malik, Z.A., G.M. Denning, and D.J. Kusner. 2000. Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. The Journal of Experimental Medicine 191: 287–302.

    Article  PubMed  CAS  Google Scholar 

  2. Rocha-Ramirez, L.M., I. Estrada-Garcia, L.M. Lopez-Marin, E. Segura-Salinas, P. Mendez-Aragon, D. Van Soolingen, et al. 2008. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis (Edinburgh, Scotland) 88: 212–220.

    Article  CAS  Google Scholar 

  3. del Corral, H., S.C. Paris, N.D. Marin, D.M. Marin, L. Lopez, H.M. Henao, et al. 2009. IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One 4: e8257.

    Article  PubMed  Google Scholar 

  4. Caws, M., G. Thwaites, S. Dunstan, T.R. Hawn, N.T. Lan, N.T. Thuong, et al. 2008. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathogens 4: e1000034.

    Article  PubMed  Google Scholar 

  5. Chan, J., and J. Flynn. 2004. The immunological aspects of latency in tuberculosis. Clinical Immunology 110: 2–12.

    Article  PubMed  CAS  Google Scholar 

  6. Antas, P.R., F.L. Cardoso, K.C. Pereira, K.L. Franken, K.S. Cunha, P. Klatser, et al. 2005. T cell immune responses to mycobacterial antigens in Brazilian tuberculosis patients and controls. Transactions of the Royal Society of Tropical Medicine and Hygiene 99: 699–707.

    Article  PubMed  CAS  Google Scholar 

  7. Tufariello, J.M., J. Chan, and J.L. Flynn. 2003. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. The Lancet Infectious Diseases 3: 578–590.

    Article  PubMed  CAS  Google Scholar 

  8. Reiter, R.J. 1991. Melatonin: the chemical expression of darkness. Molecular and Cellular Endocrinology 79: C153–C158.

    Article  PubMed  CAS  Google Scholar 

  9. Reiter, R.J., D.X. Tan, E. Sanchez-Barcelo, M.D. Mediavilla, E. Gitto, and A. Korkmaz. 2011. Circadian mechanisms in the regulation of melatonin synthesis: disruption with light at night and the pathophysiological consequences. Journal of Experimental and Integrative Medicine 1: 13–22.

    Article  Google Scholar 

  10. Reiter, R.J. 1993. The melatonin rhythm: both a clock and a calendar. Experientia 49: 654–664.

    Article  PubMed  CAS  Google Scholar 

  11. Reiter, R.J., S.D. Paredes, A. Korkmaz, L.C. Manchester, and D.X. Tan. 2008. Melatonin in relation to the “strong” and “weak” versions of the free radical theory of aging. Advances in Medical Sciences 53: 119–129.

    Article  PubMed  CAS  Google Scholar 

  12. Poeggeler, B. 2005. Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine 27: 201–212.

    Article  PubMed  CAS  Google Scholar 

  13. Reiter, R.J., D.X. Tan, and L. Fuentes-Broto. 2010. Melatonin: a multitasking molecule. Progress in Brain Research 181: 127–151.

    Article  PubMed  CAS  Google Scholar 

  14. Macchi, M.M., and J.N. Bruce. 2004. Human pineal physiology and functional significance of melatonin. Frontiers in Neuroendocrinology 25: 177–195.

    Article  PubMed  CAS  Google Scholar 

  15. Srinivasan, V., D.P. Cardinali, S.R. Pandi-Perumal, and G.M. Brown. 2011. Melatonin agonists for treatment of sleep and depressive disorders. Journal of Experimental and Integrative Medicine 1: 149–158.

    Article  Google Scholar 

  16. Terron, M.P., J. Delgado, S.D. Paredes, C. Barriga, R.J. Reiter, and A.B. Rodriguez. 2009. Effect of melatonin and tryptophan on humoral immunity in young and old ringdoves (Streptopelia risoria). Experimental Gerontology 44: 653–658.

    Article  PubMed  CAS  Google Scholar 

  17. Santello, F.H., E.O. Frare, C.D. dos Santos, and L.C. Caetano. 2008. Alonso Toldo MP, do Prado JC, Jr. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi. Journal of Pineal Research 45: 291–296.

    Article  PubMed  CAS  Google Scholar 

  18. Arendt, J., C. Bojkowski, C. Franey, J. Wright, and V. Marks. 1985. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. Journal of Clinical Endocrinology and Metabolism 60: 1166–1173.

    Article  PubMed  CAS  Google Scholar 

  19. Wisniewska-Jarosinska, M., J. Chojnacki, S. Konturek, T. Brzozowski, J. Smigielski, and C. Chojnacki. 2010. Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome. Journal of Physiology and Pharmacology 61: 295–300.

    PubMed  CAS  Google Scholar 

  20. Ozkan E, Yaman H, Cakir E, Aydin I, Oztosun M, Agilli M, et al. 2012. The measurement of plasma melatonin levels by high performance liquid chromatography. Journal of Experimental and Integrative Medicine 2: 85–88.

    Google Scholar 

  21. Guerrero, J.M., and R.J. Reiter. 2002. Melatonin-immune system relationships. Current Topics in Medicinal Chemistry 2: 167–179.

    Article  PubMed  CAS  Google Scholar 

  22. Lissoni, P., F. Rovelli, F. Brivio, O. Brivio, and L. Fumagalli. 1998. Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans. Natural Immunity 16: 1–5.

    Article  PubMed  CAS  Google Scholar 

  23. Maestroni, G.J., A. Conti, and W. Pierpaoli. 1986. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. Journal of Neuroimmunology 13: 19–30.

    Article  PubMed  CAS  Google Scholar 

  24. Jankovic, B.D., K. Isakovic, and S. Petrovic. 1970. Effect of pinealectomy on immune reactions in the rat. Immunology 18: 1–6.

    PubMed  CAS  Google Scholar 

  25. Carrillo-Vico, A., J.M. Guerrero, P.J. Lardone, and R.J. Reiter. 2005. A review of the multiple actions of melatonin on the immune system. Endocrine 27: 189–200.

    Article  PubMed  CAS  Google Scholar 

  26. Caroleo, M.C., D. Frasca, G. Nistico, and G. Doria. 1992. Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology 23: 81–89.

    Article  PubMed  CAS  Google Scholar 

  27. Garcia-Maurino, S., M.G. Gonzalez-Haba, J.R. Calvo, M. Rafii-El-Idrissi, V. Sanchez-Margalet, R. Goberna, et al. 1997. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. Journal of Immunology 159: 574–581.

    CAS  Google Scholar 

  28. Santello, F.H. 2009. Del Vecchio Filipin M, Caetano LC, Brazao V, Caetano LN, Dos Santos CD, et al. Influence of melatonin therapy and orchiectomy on T cell subsets in male Wistar rats infected with Trypanosoma cruzi. Journal of Pineal Research 47: 271–276.

    Article  PubMed  CAS  Google Scholar 

  29. Terron Mdel, P., S.D. Paredes, C. Barriga, E. Ortega, R.J. Reiter, and A.B. Rodriguez. 2005. Oral administration of melatonin to old ring doves (Streptopelia risoria) increases plasma levels of melatonin and heterophil phagocytic activity. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 60: 44–50.

    Article  PubMed  Google Scholar 

  30. Rodriguez, A.B., and R.W. Lea. 1994. Effect of pinealectomy upon the nonspecific immune response of the ring-dove (Streptopelia risoria). Journal of Pineal Research 16: 159–166.

    Article  PubMed  CAS  Google Scholar 

  31. Siopes, T.D., and H.A. Underwood. 2008. Diurnal variation in the cellular and humoral immune responses of Japanese quail: role of melatonin. General and Comparative Endocrinology 158: 245–249.

    Article  PubMed  CAS  Google Scholar 

  32. Raghavendra, V., V. Singh, S.K. Kulkarni, and J.N. Agrewala. 2001. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Molecular and Cellular Biochemistry 221: 57–62.

    Article  PubMed  CAS  Google Scholar 

  33. Skwarlo-Sonta, K. 2002. Melatonin in immunity: comparative aspects. Neuro Endocrinology Letters 23(Suppl 1): 61–66.

    PubMed  CAS  Google Scholar 

  34. Rai, S., and C. Haldar. 2003. Pineal control of immune status and hematological changes in blood and bone marrow of male squirrels (Funambulus pennanti) during their reproductively active phase. Comparative Biochemistry and Physiology—Part C: Toxicology & Pharmacology 136: 319–328.

    Article  CAS  Google Scholar 

  35. Nagayama, N., and M. Ohmori. 2006. Seasonality in various forms of tuberculosis. The International Journal of Tuberculosis and Lung Disease 10: 1117–1122.

    PubMed  CAS  Google Scholar 

  36. Thorpe, L.E., T.R. Frieden, K.F. Laserson, C. Wells, and G.R. Khatri. 2004. Seasonality of tuberculosis in India: is it real and what does it tell us? Lancet 364: 1613–1614.

    Article  PubMed  Google Scholar 

  37. Singh, S.S., and C. Haldar. 2007. Peripheral melatonin modulates seasonal immunity and reproduction of Indian tropical male bird Perdicula asiatica. Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology 146: 446–450.

    Article  Google Scholar 

  38. Meylan, P.R., D.D. Richman, and R.S. Kornbluth. 1992. Reduced intracellular growth of mycobacteria in human macrophages cultivated at physiologic oxygen pressure. American Review of Respiratory Disease 145: 947–953.

    PubMed  CAS  Google Scholar 

  39. Oberley-Deegan, R.E., B.W. Rebits, M.R. Weaver, A.K. Tollefson, X. Bai, M. McGibney, et al. 2010. An oxidative environment promotes growth of Mycobacterium abscessus. Free Radical Biology & Medicine 49: 1666–1673.

    Article  CAS  Google Scholar 

  40. Hardeland, R., D.X. Tan, and R.J. Reiter. 2009. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. Journal of Pineal Research 47: 109–126.

    Article  PubMed  CAS  Google Scholar 

  41. Allegra, M., R.J. Reiter, D.X. Tan, C. Gentile, L. Tesoriere, and M.A. Livrea. 2003. The chemistry of melatonin’s interaction with reactive species. Journal of Pineal Research 34: 1–10.

    Article  PubMed  CAS  Google Scholar 

  42. Andersen, P., and I. Heron. 1993. Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infection and Immunity 61: 844–851.

    PubMed  CAS  Google Scholar 

  43. Condos, R., W.N. Rom, Y.M. Liu, and N.W. Schluger. 1998. Local immune responses correlate with presentation and outcome in tuberculosis. American Journal of Respiratory and Critical Care Medicine 157: 729–735.

    PubMed  CAS  Google Scholar 

  44. Budak, F., E.K. Uzaslan, S. Cangur, G. Goral, and H.B. Oral. 2008. Increased pleural soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines. Lung 186: 337–343.

    Article  PubMed  CAS  Google Scholar 

  45. Carrillo-Vico, A., A. Garcia-Perganeda, L. Naji, J.R. Calvo, M.P. Romero, and J.M. Guerrero. 2003. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cellular and Molecular Life Sciences 60: 2272–2278.

    Article  PubMed  CAS  Google Scholar 

  46. Cutolo, M., A. Sulli, C. Pizzorni, M.E. Secchi, S. Soldano, B. Seriolo, et al. 2006. Circadian rhythms: glucocorticoids and arthritis. Annals of the New York Academy of Sciences 1069: 289–299.

    Article  PubMed  CAS  Google Scholar 

  47. Reiter, R.J. 2003. Melatonin: clinical relevance. Best Practice & Research. Clinical Endocrinology & Metabolism 17: 273–285.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Halil Yaman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozkan, E., Yaman, H., Cakir, E. et al. Plasma Melatonin and Urinary 6-Hydroxymelatonin Levels in Patients with Pulmonary Tuberculosis. Inflammation 35, 1429–1434 (2012). https://doi.org/10.1007/s10753-012-9456-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-012-9456-3

KEY WORDS

Navigation